Marshall Wace
MHUA

Marshall Wace’s Meihua International Medical Technologies MHUA Stock Holding History

Marshall Wace’s Portfolio MHUA Stock Details MHUA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-111
Closed -$8.42K – 2791
2024
Q1 		$8.42K Sell
111
-1,364
-92% -$121K ﹤0.01% 2377
2023
Q4 		$218K Buy
+1,475
New +$271K ﹤0.01% 1959

Other funds holding MHUA

AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
MG
Marex Group London $15.8B AUM 31.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Marshall Wace's MHUA Position: Q2 2024 in Review

Marshall Wace sold out of Meihua International Medical Technologies (MHUA) in Q2 2024, closing a stake of 111 shares — an estimated $8.42K sold.

Marshall Wace first reported a position in MHUA in Q4 2023 and held it in 2 quarters. The position peaked at $218K in Q4 2023. 6 funds tracked by Wall St. Rank hold MHUA as of Q2 2024.

  • Marshall Wace reported no remaining Meihua International Medical Technologies position as of Q2 2024 after selling out during the quarter.
  • Marshall Wace sold 111 Meihua International Medical Technologies shares in Q2 2024, an estimated $8.42K.
  • Marshall Wace first reported a position in Meihua International Medical Technologies in Q4 2023 and held it in 2 quarters.
  • Marshall Wace's Meihua International Medical Technologies position peaked at $218K in Q4 2023.
  • 6 funds tracked by Wall St. Rank held Meihua International Medical Technologies as of Q2 2024.

Based on Marshall Wace's 13F filing for Q2 2024, filed 14 Aug 2024.